MMA
HALO icon

Miracle Mile Advisors’s Halozyme HALO Stock Holding History

Miracle Mile Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Buy
4,684
+50
+1% +$3.41K ﹤0.01% 729
2026
Q1 		$299K Hold
4,634
– – ﹤0.01% 731
2025
Q4 		$312K Buy
4,634
+45
+1% +$3.03K ﹤0.01% 694
2025
Q3 		$337K Sell
4,589
-11
-0.2% -$731 0.01% 650
2025
Q2 		$239K Buy
4,600
+151
+3% +$8.59K ﹤0.01% 645
2025
Q1 		$284K Buy
4,449
+30
+0.7% +$1.74K 0.01% 532
2024
Q4 		$211K Buy
4,419
+74
+2% +$3.79K ﹤0.01% 593
2024
Q3 		$249K Hold
4,345
– – 0.01% 460
2024
Q2 		$228K Buy
+4,345
New +$191K 0.01% 450

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Miracle Mile Advisors's HALO Position: Q2 2026 in Review

Miracle Mile Advisors increased its Halozyme (HALO) stake by 1.1% in Q2 2026, buying an estimated $3.41K and bringing the position to 4,684 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Miracle Mile Advisors first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Miracle Mile Advisors held 4,684 shares of Halozyme worth $367K as of Q2 2026.
  • Miracle Mile Advisors bought 50 Halozyme shares in Q2 2026, an estimated $3.41K.
  • Halozyme made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #729 holding.
  • Miracle Mile Advisors first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.